Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5664 of 5804
-
Healthy volunteers test two pens for growth hormone delivery
Knowledge-focused Recruiting nowThe purpose of this clinical study is to learn about how different injector pens affect: * how the study medicine (called Genotropin) is delivered into the body and * how the study medicine is taken up into the blood in healthy adults. The study is seeking participants who are:…
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Healthy volunteers compare two methods of delivering navenibart
Knowledge-focused Recruiting nowThe goal of this clinical trial is to compare two different presentations (vial and syringe versus autoinjector) of navenibart in healthy adult volunteers. The main questions it aims to answer are: * Do these presentations lead to similar drug concentrations in the blood? * Do t…
Phase: PHASE1 • Sponsor: Astria Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Healthy volunteers needed to test two versions of cholesterol drug
Knowledge-focused OngoingThe primary objective of this trial is to evaluate the pharmacokinetics (PK) of two evolocumab drug products in healthy participants.
Phase: PHASE1 • Sponsor: Amgen • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Healthy volunteers to test how new drug enters the body
Knowledge-focused Recruiting nowThe main purpose of this study is to evaluate how eltrekibart is absorbed by the body when it is given under the skin to healthy participants. The study will last about 17 weeks.
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New drug nacresertib gets first safety check in healthy volunteers
Knowledge-focused CompletedA Study to Assess Adverse Events, Tolerability and How a Single Oral Dose of Nacresertib Moves Through the Body In Healthy Adult Japanese Participants
Phase: PHASE1 • Sponsor: AbbVie • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC
-
Asthma inhaler showdown: generic vs. Brand-Name – study pulled before start
Disease control TerminatedThis is a randomized, multi-center, multiple-dose, double-blind, placebo-controlled, Parallel group design, clinical endpoint bioequivalence study in adult participants with asthma. The study design includes up to a 2-week Screening period, at least a 2-week Run-in period, a 4-w…
Phase: PHASE3 • Sponsor: Sandoz • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New skin serum passes safety check in small trial
Symptom relief CompletedThe objective of this study is to investigate the safety of 1 topically applied test article containing Mitopure in a panel of healthy volunteers.
Phase: NA • Sponsor: Amazentis SA • Aim: Symptom relief
Last updated Jun 27, 2026 13:07 UTC
-
Scientists dig into dental plaque to unlock gum disease secrets
Knowledge-focused Recruiting nowThe objective of this clinical research study is to collect and analyze plaque and oral health measures in a population with high plaque/low gingivitis and high plaque/high gingivitis
Phase: PHASE4 • Sponsor: Colgate Palmolive • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Healthy volunteers needed to test new injection method for experimental drug
Knowledge-focused Not yet recruitingThis is a randomized, open-label, parallel-controlled study to compare the PK, safety, and immunogenicity of CM326 administered via different delivery devices in healthy subjects.
Phase: PHASE1 • Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:25 UTC
-
Liver function and drug levels: a closer look at GS1-144
Knowledge-focused Not yet recruitingGS1-144 in Participants with Hepatic Impairment and Healthy Female
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New drug GenSci161 tested for safety in healthy people
Knowledge-focused Recruiting nowTo Evaluate the Safety and Tolerability, Pharmacokinetics and Biomarker of GenSci161 in a Randomized, Double-blind, Placebo-controlled Study in Healthy Adult Participants.
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Mitopure skin serum passes safety check in 112 volunteers
Symptom relief CompletedThe objective of this study is to investigate the irritation and sensitization potential of 1 topically applied test article containing Mitopure in a shared panel of healthy volunteers by means of repeated cutaneous patch applications under occlusion based on the modified Draize …
Phase: NA • Sponsor: Amazentis SA • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Spine surgery tool tested for better alignment
Knowledge-focused TerminatedThis study will prospectively collect data to evaluate the effectiveness of a novel intraoperative spinal measurement system to assist the surgeon with intraoperatively achieving pre-planned alignment-related parameters to the patient's spine. The study will also collect outcomes…
Phase: NA • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Spinal injury study probes Mind's eye for movement
Knowledge-focused Not yet recruitingIndividuals aged 18-65 years who have been clinically diagnosed with spinal cord injury and have developed paraplegia will be included in the study. Demographic and clinical data of the participants, including age, sex, height, weight, etiology of injury, level of injury, duratio…
Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New drug LG-0317 tested in people for the first time
Knowledge-focused Recruiting nowThis study is the first administration of LG-0317 to humans. The purpose of the study is to evaluate safety/tolerability and pharmacokinetics in healthy subjects. The intention of this study is to provide confidence in the safety of the molecule to inform progression to further p…
Phase: PHASE1 • Sponsor: LinGang Laboratory • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Tiny study checks if collagen causes skin allergies
Knowledge-focused CompletedThis study evaluates the allergic (immunogenic) response following application of a collagen-based material in healthy adult volunteers using a standardized skin prick test. Skin responses will be assessed at multiple time points following application.
Phase: NA • Sponsor: SerenaGroup, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Frozen or fresh? new study tests vitamin d lab accuracy
Knowledge-focused ENROLLING_BY_INVITATIONThis study evaluates the stability of 25-hydroxyvitamin D \[25(OH)D\] measurements in human serum and plasma using the ALPCO 25(OH) Vitamin D CLIA Kit. The study compares results obtained from fresh specimens with those obtained after storage under various temperature and time co…
Sponsor: American Laboratory Products Company • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New drug ZE74-0282 tested in healthy people for first time
Knowledge-focused Recruiting nowA first-in-human study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single doses under fasted and fed conditions of ZE74-0282 administered orally in healthy volunteers.
Phase: PHASE1 • Sponsor: Eilean Therapeutics AU Pty Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
TAVR pacemaker study withdrawn before enrolling any patients
Knowledge-focused TerminatedThe RAFT-TAVR PACE study is a clinical trial designed to compare two types of heart pacing methods in patients who develop conduction problems after undergoing a transcatheter aortic valve replacement (TAVR) procedure. This study will evaluate whether Left Bundle Branch Area Pac…
Phase: NA • Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a Yeast-Based spray beat body odor? small study seeks answers
Symptom relief CompletedThe goal of this clinical trial is to evaluate the performance of NOBO, a yeast-based fermentation product (postbiotic) designed to control axillary odor, in controlling axillary odor in healthy male and female adults age 18 - 70 with confirmed self-perception of body odor. The m…
Phase: NA • Sponsor: Kingdom • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC